Phase 1 Safety and Pharmacokinetics Study of MK-2048/Vicriviroc (MK-4176)/MK-2048A Intravaginal Rings

BACKGROUND: Vaginal rings (VR) containing antiretroviral (ARV) drugs can be utilized for prevention of human immunodeficiency virus (HIV) with potential for improved adherence compared to daily pills. Combination ARV VRs could improve efficacy. METHODS: MTN-027, a single-blind, randomized, placebo-c...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Clin Infect Dis
Päätekijät: Hoesley, Craig J, Chen, Beatrice A, Anderson, Peter L, Dezzutti, Charlene S, Strizki, Julie, Sprinkle, Carol, Heard, Faye, Bauermeister, Jose, Hall, Wayne, Jacobson, Cindy, Berthiaume, Jennifer, Mayo, Ashley, Gundacker, Holly, Richardson-Harman, Nicola, Piper, Jeanna
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2019
Aiheet:
Articles and Commentaries
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6424075/
https://ncbi.nlm.nih.gov/pubmed/30289435
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciy653
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia